From antibiotic resistance to emerging viral threats, the global demand for new medicines is intensifying, yet traditional drug discovery pipelines remain slow and expensive. A new scientific review ...
The collaboration will combine Syngene’s preclinical development expertise with VivaMed's AI-generated therapeutic hypotheses ...
Hosted on MSN
AI is helping doctors repurpose old drugs for new cures: 'The solution is in your neighborhood pharmacy'
When David Fajgenbaum was in medical school, he was diagnosed with an incurable illness called Castleman disease. He was 25 years old when doctors told him “there’s nothing we can do,” and a priest ...
And there's more than one way to monetize this technology.
Explore the impact of AI in drug discovery as 2026 promises critical clinical results and industry transformations.
Hyderabad-based SCIINV Biosciences has identified a new AI-driven repurposed antibiotic now entering human clinical trials. The breakthrough, backed by Whale Tank Biocatalyst, reduces development time ...
The study in brief: Cancer research//Basic research//Peer review publication//Researcher-initiated study//Computer simulation//Animal study//In vitro/In vivo//In ...
IAN Alpha Fund, the 2nd in the series of IAN Group’s VC funds, along with Speciale Invest, has co-led a ₹70 crore Series A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results